• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      US court rules against Ranbaxy, supports Pfizer patent

      Posted AtNewratings.com

      NEW YORK, November 24 (newratings.com "The court of appeals for the federal circuit in Washington on Wednesday upheld a preliminary injunction granted by the US district court of New Jersey, barring Ranbaxy Pharmaceuticals Inc from marketing a generic version of Pfizer's (PFE.NYS) Quinapril HCI tablets.

      The US Court of Appeals for the Federal Circuit Wednesday affirmed Judge Dickinson R Debevoise's earlier order to stop selling a generic version of Pfizer's Accupril drug by Gurgaon, India-based Ranbaxy Pharmaceuticals, a subsidiary of Ranbaxy Laboratories (RLYG). Pfizer said that it would seek damages from Ranbaxy and co-promoter Teva Pharmaceutical Industries (TEVA) for lost revenues from Quinapril. Ranbaxy's share price fell Rs.8.1 or 2.2% to Rs.368.8 on the Mumbai stock exchange on Thursday.

      November 24, 2005


       

      Share this Article!

    Back to top^